The investigational medication retatrutide not only resulted in weight loss among patients with obes...
Adults with alcohol use disorder (AUD) and comorbid obesity who took once-weekly semaglutide signifi...
The Food and Drug Administration (FDA) this week requested that manufacturers of glucagon-like pepti...
Researchers are exploring the potential of glucagon-like peptide 1 (GLP-1) receptor agonists to trea...












